Cyrano Therapeutics

Cyrano Therapeutics is developing an intranasal product aimed at restoring function in patients suffering from chronic loss of taste and smell. The company’s product (CYR-001) repurposes an approved molecule (theophylline) for this new indication and has been successfully tested in an initial study.